{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:17:54Z","timestamp":1778624274462,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.oooo.2015.06.027","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T11:39:06Z","timestamp":1436096346000},"page":"497-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["High expression of survivin and its splice variants survivin \u0394Ex3 and survivin 2 B in oral cancers"],"prefix":"10.1016","volume":"120","author":[{"given":"Rupa","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinayak","family":"Palve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhana","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanuja","family":"Teni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2015.06.027_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0970-4388.50808","article-title":"The genomics of oral cancer and wound healing","volume":"27","author":"Aswini","year":"2009","journal-title":"J\u00a0Indian Soc Pedod Prevent Dent"},{"key":"10.1016\/j.oooo.2015.06.027_bib2","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/cancers6031705","article-title":"Human papillomavirus in head and neck cancer","volume":"6","author":"Garbuglia","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.oooo.2015.06.027_bib3","doi-asserted-by":"crossref","first-page":"10559","DOI":"10.1128\/JVI.76.20.10559-10568.2002","article-title":"Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells","volume":"76","author":"Helt","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.oooo.2015.06.027_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0964-1955(94)90036-1","article-title":"Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines","volume":"30B","author":"Min","year":"1994","journal-title":"Eur J Cancer Part B, Oral Oncol"},{"key":"10.1016\/j.oooo.2015.06.027_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1368-8375(98)00110-9","article-title":"p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India","volume":"35","author":"Saranath","year":"1999","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2015.06.027_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bjc.6690505","article-title":"Role of p16\/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines","volume":"80","author":"Sartor","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/carcin\/bgm219","article-title":"Survivin repression by p53, Rb and E2 F2 in normal human melanocytes","volume":"29","author":"Raj","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.oooo.2015.06.027_bib8","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/JVI.75.9.4283-4296.2001","article-title":"Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes","volume":"75","author":"Nees","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.oooo.2015.06.027_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/PAI.0b013e31828a0d0c","article-title":"Overexpression of survivin and caspase 3 in oral carcinogenesis","volume":"22","author":"Poomsawat","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.oooo.2015.06.027_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.oooo.2014.02.005","article-title":"Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck","volume":"117","author":"Pickhard","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2015.06.027_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/med.21264","article-title":"Survivin signaling in clinical oncology: a multifaceted dragon","volume":"33","author":"Kanwar","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.oooo.2015.06.027_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.bjc.6602340","article-title":"Role of survivin and its splice variants in tumorigenesis","volume":"92","author":"Li","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/jclinpath-2011-200066","article-title":"Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma","volume":"64","author":"Huang","year":"2011","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.oooo.2015.06.027_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4174\/jkss.2011.80.6.404","article-title":"Expression of the survivin-2 B splice variant related to the progression of colorectal carcinoma","volume":"80","author":"Cho","year":"2011","journal-title":"J\u00a0Korean Surg Soc"},{"key":"10.1016\/j.oooo.2015.06.027_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.scr.2014.01.002","article-title":"Differential localization and high expression of SURVIVIN splice variants in human embryonic stem cells but not in differentiated cells implicate a role for SURVIVIN in pluripotency","volume":"12","author":"Mull","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.oooo.2015.06.027_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0973-1482.136598","article-title":"Detection of survivin 2 alpha gene expression in thyroid nodules","volume":"10","author":"Kyani","year":"2014","journal-title":"J\u00a0Cancer Res Therap"},{"key":"10.1016\/j.oooo.2015.06.027_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12032-013-0535-6","article-title":"Expression of survivin and its four splice variants in colorectal cancer and its clinical significances","volume":"30","author":"Ge","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.oooo.2015.06.027_bib18","first-page":"1235","article-title":"Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60\/ADR cell line","volume":"24","author":"Wang","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.oooo.2015.06.027_bib19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1349-7006.2000.tb00906.x","article-title":"Survivin as a radioresistance factor in pancreatic cancer","volume":"91","author":"Asanuma","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.oooo.2015.06.027_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcdb.2014.12.007","article-title":"Survivin\u2014the inconvenient IAP","volume":"39","author":"Altieri","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.oooo.2015.06.027_bib21","first-page":"202","article-title":"Survivin and YM155: how faithful is the liaison?","volume":"1845","author":"Rauch","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.oooo.2015.06.027_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2012.03.005","article-title":"Targeting survivin in cancer","volume":"332","author":"Altieri","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.oooo.2015.06.027_bib23","doi-asserted-by":"crossref","first-page":"27204","DOI":"10.1074\/jbc.M705161200","article-title":"Forced expression of survivin-2 B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivin","volume":"282","author":"Ling","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.oooo.2015.06.027_bib24","doi-asserted-by":"crossref","first-page":"16207","DOI":"10.1074\/jbc.M600539200","article-title":"Apoptosis induction by activator protein 2 alpha involves transcriptional repression of Bcl-2","volume":"281","author":"Wajapeyee","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.oooo.2015.06.027_bib25","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/sj.onc.1208350","article-title":"Survivin splice variants regulate the balance between proliferation and cell death","volume":"24","author":"Caldas","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.oooo.2015.06.027_bib26","first-page":"6097","article-title":"Survivin-deltaEx3 and survivin-2 B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties","volume":"59","author":"Mahotka","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.oooo.2015.06.027_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2013.06.007","article-title":"Clinico-pathologic relevance of Survivin splice variant expression in cancer","volume":"339","author":"Necochea-Campion","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.oooo.2015.06.027_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/gtmb.2012.0411","article-title":"Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3 alpha in breast cancer","volume":"17","author":"Moniri Javadhesari","year":"2013","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.oooo.2015.06.027_bib29","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1038\/sj.onc.1208038","article-title":"An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy","volume":"23","author":"Zhu","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.oooo.2015.06.027_bib30","doi-asserted-by":"crossref","unstructured":"Tazo Y, Hara A, Onda T, Saegusa M. Bifunctional roles of survivin-DeltaEx3 and survivin-2 B for susceptibility to apoptosis in endometrial carcinomas. J Cancer Res Clin Oncol. 2014 Jul 12 [Epub ahead of print].","DOI":"10.1007\/s00432-014-1762-8"},{"key":"10.1016\/j.oooo.2015.06.027_bib31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/neuonc\/nou034","article-title":"Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas","volume":"16","author":"Doucette","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.oooo.2015.06.027_bib32","doi-asserted-by":"crossref","first-page":"e100534","DOI":"10.1371\/journal.pone.0100534","article-title":"Survivin delta ex3 overexpression in thyroid malignancies","volume":"9","author":"Waligorska-Stachura","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.oooo.2015.06.027_bib33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bjc.6604253","article-title":"The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers","volume":"98","author":"Nakano","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00432-008-0433-z","article-title":"Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma","volume":"135","author":"De Maria","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.oooo.2015.06.027_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01612674","article-title":"Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors","volume":"116","author":"Tatake","year":"1990","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.oooo.2015.06.027_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.oraloncology.2007.05.003","article-title":"Chromosomal imbalances in oral squamous cell carcinoma: Examination of 31 cell lines and review of the literature","volume":"44","author":"Martin","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2015.06.027_bib37","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.2910520612","article-title":"DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype","volume":"52","author":"Chang","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib38","doi-asserted-by":"crossref","first-page":"e97777","DOI":"10.1371\/journal.pone.0097777","article-title":"Raman spectroscopic study of radioresistant oral cancer sublines established by fractionated ionizing radiation","volume":"9","author":"Yasser","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.oooo.2015.06.027_bib39","doi-asserted-by":"crossref","first-page":"e111927","DOI":"10.1371\/journal.pone.0111927","article-title":"Overexpression of Mcl-1 L splice variant is associated with poor prognosis and chemoresistance in oral cancers","volume":"9","author":"Palve","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.oooo.2015.06.027_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.bjc.6602317","article-title":"Survivin, Survivin-2 B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome","volume":"92","author":"Fangusaro","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-4598-4-11","article-title":"Survivin 2 alpha: a novel Survivin splice variant expressed in human malignancies","volume":"4","author":"Caldas","year":"2005","journal-title":"Mol Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.oooo.2015.06.027_bib43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3322\/canjclin.55.4.242","article-title":"TNM staging of cancers of the head and neck: striving for uniformity among diversity","volume":"55","author":"Patel","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.oooo.2015.06.027_bib44","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A\u00a0novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.oooo.2015.06.027_bib45","first-page":"453","article-title":"Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines","volume":"20","author":"Farnebo","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oooo.2015.06.027_bib46","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/sj.onc.1205353","article-title":"Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway","volume":"21","author":"Mirza","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.oooo.2015.06.027_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/humu.10248","article-title":"Detection and assignment of TP53 mutations in tumor DNA using peptide mass signature genotyping","volume":"22","author":"Telmer","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.oooo.2015.06.027_bib48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/bjc.1994.356","article-title":"The p53 status of cultured human premalignant oral keratinocytes","volume":"70","author":"Burns","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1099\/vir.0.81067-0","article-title":"Effects of human papillomavirus type 16 oncoproteins on survivin gene expression","volume":"87","author":"Borbely","year":"2006","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.oooo.2015.06.027_bib50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.oraloncology.2005.02.009","article-title":"Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan","volume":"41","author":"Lin","year":"2005","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2015.06.027_bib51","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clbc.2013.10.012","article-title":"Validation of a real-time quantitative polymerase chain reaction method for the quantification of 3 survivin transcripts and evaluation in breast cancer tissues","volume":"14","author":"Pavlidou","year":"2014","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2407-14-176","article-title":"Early diagnostic value of survivin and its alternative splice variants in breast cancer","volume":"14","author":"Khan","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0973-1482.87038","article-title":"Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma","volume":"7","author":"Vandghanooni","year":"2011","journal-title":"J\u00a0Cancer Res Ther"},{"key":"10.1016\/j.oooo.2015.06.027_bib54","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3748\/wjg.v17.i12.1614","article-title":"Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR","volume":"17","author":"Pavlidou","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.oooo.2015.06.027_bib55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cdp.2008.12.001","article-title":"Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2 B, in bladder cancer","volume":"32","author":"Atlasi","year":"2009","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.oooo.2015.06.027_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/0973-1482.113365","article-title":"The histological characteristics of clinically normal mucosa adjacent to oral cancer","volume":"9","author":"Cankovic","year":"2013","journal-title":"J\u00a0Cancer Res Therap"},{"key":"10.1016\/j.oooo.2015.06.027_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.onc.1209770","article-title":"Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer","volume":"26","author":"Roesch-Ely","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.oooo.2015.06.027_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2867-7-2","article-title":"Clinical implications and utility of field cancerization","volume":"7","author":"Dakubo","year":"2007","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.oooo.2015.06.027_bib59","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1373\/clinchem.2006.071613","article-title":"Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?","volume":"52","author":"Span","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.oooo.2015.06.027_bib60","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1158\/0008-5472.CAN-13-0036","article-title":"Survivin-3 B potentiates immune escape in cancer but also inhibits the toxicity of cancer chemotherapy","volume":"73","author":"Vegran","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.oooo.2015.06.027_bib61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/ERC-11-0105","article-title":"Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma","volume":"18","author":"Vegran","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib62","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pbc.24822","article-title":"BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group","volume":"61","author":"Moore","year":"2014","journal-title":"Ped Blood Cancer"},{"key":"10.1016\/j.oooo.2015.06.027_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canep.2009.06.005","article-title":"Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer","volume":"33","author":"Okamura","year":"2009","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.oooo.2015.06.027_bib64","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-11-0233","article-title":"Silencing survivin splice variant 2 B leads to antitumor activity in taxane\u2013resistant ovarian cancer","volume":"17","author":"Vivas-Mejia","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oooo.2015.06.027_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1155\/2010\/673592","article-title":"The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival","volume":"33","author":"Antonacopoulou","year":"2010","journal-title":"Analyt Cell Pathol"},{"key":"10.1016\/j.oooo.2015.06.027_bib66","first-page":"285","article-title":"Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy","volume":"23","author":"Boidot","year":"2009","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.oooo.2015.06.027_bib67","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.4161\/cc.6.12.4305","article-title":"The survivin isoform survivin-3 B is cytoprotective and can function as a chromosomal passenger complex protein","volume":"6","author":"Knauer","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.oooo.2015.06.027_bib68","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1074\/jbc.M508773200","article-title":"Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis","volume":"281","author":"Noton","year":"2006","journal-title":"J\u00a0Biol Chem"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440315010664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440315010664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T20:38:52Z","timestamp":1566938332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440315010664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2212440315010664"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2015.06.027","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression of survivin and its splice variants survivin \u0394Ex3 and survivin 2 B in oral cancers","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2015.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}